Skip to main content
TipRanks
Go Ultimate75% OFF

Neurocrine (NB3) Q2 2023 Earnings Report

0 Followers

CH:NB3 Q2 2023 EPS Results

Actual EPS
CHF 0.80
Consensus EPS
CHF 0.68
Beat/Miss
Beat by +CHF 0.11
One Year Ago EPS
-CHF 0.15

CH:NB3 Q2 2023 Revenue Results

Actual Revenue
CHF 379.88M
Expected Revenue
CHF 375.38M
Beat/Miss
Beat by +CHF 4.50M
YoY Revenue Growth
+19.70%

Earnings Announcement Details

Quarter
Q2 2023
Date
08/01/2023
Time
Before Open
Conference Call
Tuesday, August 1, 2023
CH:NB3 Upcoming Earnings

Neurocrine's next earnings date is estimated for February 11, 2027, based on past reporting schedules.

Q2 2023 Earnings Call Audio

CH:NB3 Q2 2023 Earnings Call
0:00 / 0:00

Q2 2023 Earnings Slide Deck

Q2 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

CH:NB3 Earnings History

CH:NB3 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 11, 20272026 (Q4)1.74-1.24――
Nov 02, 20262026 (Q3)1.601.641.71-3.92% (-0.07)
Jul 30, 20262026 (Q2)1.381.170.8931.13% (+0.28)
May 05, 20262026 (Q1)1.021.600.072287.50% (+1.54)
Feb 11, 20262025 (Q4)1.511.240.8448.00% (+0.40)
Oct 28, 20252025 (Q3)1.341.711.0464.52% (+0.67)
Jul 30, 20252025 (Q2)0.810.890.5368.25% (+0.36)
May 05, 20252025 (Q1)0.450.070.35-80.95% (-0.29)
Feb 06, 20252024 (Q4)1.350.841.21-30.56% (-0.37)
Oct 30, 20242024 (Q3)1.251.040.6951.22% (+0.35)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed